What if part of the treatment for a serious mental illness arrived not in a pill bottle, but in a box of groceries?
On October 14, 2026, the Baszucki Group announced funding for a new clinical study that asks exactly that question. Researchers at the University of Alabama at Birmingham's Heersink School of Medicine Montgomery Regional Campus will test whether ketogenic therapy — a medical diet already used for a century in epilepsy — can help people living with bipolar disorder in rural Central Alabama.
The study's design is as interesting as its science. Instead of asking participants to find and afford special foods on their own, researchers are partnering with the Heart of Alabama Food Bank. Using the food bank's established distribution network, they will deliver boxes of ketogenic food — built from Alabama-raised meats and produce — directly to participants' homes. It is one of the first attempts to take metabolic psychiatry, a young and fast-moving field, into the resource-poor rural areas where mental-health care is often hardest to find.
Here is what the study is, why researchers are excited about it, and what it could mean for the future of mental-health treatment.
What exactly is ketogenic therapy?
Ketogenic therapy is a medical form of the ketogenic diet: very high in fat, moderate in protein, and very low in carbohydrates. When the body runs out of carbohydrates to burn, the liver starts converting fat into molecules called ketones — a state known as nutritional ketosis. Ketones can travel into the brain and serve as an alternative fuel to glucose.
A ketogenic plate looks very different from a standard one:
- Eggs, cheese, meats, and fish
- Butter, olive oil, and other healthy fats
- Nuts and seeds
- Low-carbohydrate vegetables like spinach, broccoli, zucchini, and cauliflower
- Almost no bread, rice, pasta, potatoes, or sugary foods
(If you are curious about the broader principles of balanced eating, see our complete guide to healthy eating.) But a therapeutic ketogenic diet is stricter than the casual "keto" you see on social media, and in a medical trial it is planned and supervised by clinicians and dietitians.
The idea of using diet as medicine is not new. Doctors have prescribed ketogenic diets for drug-resistant epilepsy since the 1920s, and it remains one of the most evidence-backed dietary therapies in neurology. What is new is the attempt to bring that same metabolic logic to psychiatry.
Why bipolar disorder? The brain-energy connection
Bipolar disorder causes extreme swings between mania (or hypomania) and depression. Medications — including mood stabilizers and antipsychotics — help many people, but they do not work for everyone, and they come with heavy costs. Many of these drugs cause weight gain, insulin resistance, and a higher risk of type 2 diabetes. People with bipolar disorder already carry a greater metabolic burden than the general population, and the medicines they take can make it worse — a frustrating trade-off.
This is where the metabolic psychiatry hypothesis comes in. A growing body of research suggests that brain cells in people with bipolar disorder may have trouble producing energy efficiently — a problem rooted in the mitochondria, the tiny power plants inside cells. When the brain's energy supply becomes unstable, mood regulation may suffer too. Ketones could help because they provide a steadier, more efficient fuel for the brain than glucose, potentially calming the metabolic chaos behind the symptoms.
The early evidence is striking, though still preliminary. In 2024, a Stanford pilot trial led by psychiatrist Dr. Shebani Sethi put 21 adults with schizophrenia or bipolar disorder — all of whom also had metabolic problems like obesity or insulin resistance — on a closely monitored ketogenic diet for four months. The results, published in the journal Psychiatry Research: 79 percent of participants showed clinically meaningful improvement in their psychiatric symptoms, and roughly half of the participants with bipolar disorder reached remission. Every participant who had metabolic syndrome saw it go into remission as well. Adherence mattered: the more strictly people followed the diet, the better their symptoms.
A separate hospital-based study in France, co-authored by Harvard-trained psychiatrist Dr. Georgia Ede and published in 2022, followed 31 adults with severe, treatment-resistant mental illness including bipolar disorder. Of the 28 who stayed on the diet for at least two weeks, 43 percent achieved clinical remission, and 64 percent were discharged on less psychiatric medication than when they arrived.
The brain's relationship with energy goes beyond food, too — disrupted sleep, for example, throws the brain's energy systems off balance in its own way, as we explored in our explainer on the science of sleep debt. But small studies are not proof. Pilot trials are small by design, and researchers are careful to say that larger, controlled studies are needed before anyone can call ketogenic therapy an established treatment for bipolar disorder. That is precisely what the Alabama study is meant to provide.
What is metabolic psychiatry?
Metabolic psychiatry is an emerging subspecialty that treats serious mental illness by improving the body's metabolism — the way cells produce and use energy. Its central idea is simple and radical at once: the brain is an organ, organs run on energy, and fixing the brain's energy supply may fix some of what goes wrong in mental illness. The main intervention is something patients themselves can control: food.
The field is growing fast. Ketogenic trials for serious mental illness are now underway or completed at institutions including Stanford, McLean Hospital, the University of Pittsburgh, the University of Edinburgh, Oxford, the Mayo Clinic, Ohio State, UCSF, UCSD, and James Cook University. Researchers are studying not just symptoms, but mechanisms: how ketones affect neurotransmitters, inflammation, and brain metabolism.
Much of the funding momentum comes from one philanthropic source. The Baszucki Group, founded in 2021 by Roblox founder and CEO David Baszucki and his wife, author Jan Ellison Baszucki, has committed more than $11 million to ketogenic therapy research for bipolar disorder through its ReTHINK Bipolar program. The couple's interest is deeply personal: their son's bipolar disorder went into remission on medically supervised ketogenic therapy after years of hospitalizations and more than 20 medications. They have since built the Metabolic Mind initiative to spread education about metabolic psychiatry.
Why rural Alabama — and why the food-bank design is clever
Here is the part of the story that matters beyond the science. Rural Central Alabama, like many rural regions in America, faces what study lead Will Rutland, MD, calls a stark reality: "rural areas such as ours face a massive demand for mental health care and limited access to specialty services." Psychiatrists are scarce, clinics are far away, and stigma runs deep.
The study design tackles those barriers head-on. By partnering with the Heart of Alabama Food Bank, researchers plug into a distribution network that already reaches the region's most isolated households. Participants do not have to travel to a clinic or hunt down foods they cannot find or afford — ketogenic food boxes, built from Alabama-raised meats and produce, arrive at their front doors. It is a clever use of the state's agricultural strength, and it turns a charity network into a research delivery system.
The trial itself is substantial for a pilot: a six-month study of up to 100 participants across four arms, including groups taking oral mood stabilizers and groups on long-acting injectable versions. Crucially, the therapy is being tested alongside existing treatment — as an addition, not a replacement. That is both more realistic and more ethical: nobody is being asked to abandon their medication for an experimental diet.
This focus on access mirrors a broader shift in mental-health care: new tools are reaching people where they are. Just as researchers are testing how automated VR therapy is helping people with psychosis without requiring a clinic visit, the Alabama trial is testing whether the treatment itself can travel to the patient.
What this could mean beyond one trial
If the Alabama results are positive, the implications go far beyond one state. The food-bank delivery model could be copied in rural areas anywhere in the world — a template for bringing cutting-edge treatment to places that research usually ignores. It would also strengthen the case that psychiatry's future lies partly in metabolism, not just in brain chemistry: that some mental illnesses might be, at least in part, energy disorders of the brain.
There is an economic argument too. Serious mental illness is enormously expensive — in hospitalizations, lost productivity, and long-term disability. If a food-based therapy can reduce symptoms and medication load, it could pay for itself many times over, especially in underserved communities.
But honesty requires the caveats. Pilot studies are small, ketogenic diets are hard to follow, and not everyone responds. The diet has real side effects — flu-like symptoms in the first weeks, and risks that require medical supervision — and it can interact with medications. Nobody should start a ketogenic diet for a mental-health condition on their own, and nobody should stop prescribed medication because of a news article. If this research interests you, talk to your doctor or psychiatrist first.
The bottom line
A box of groceries will not replace psychiatry. But the Alabama trial is testing something psychiatry has needed for a long time: a treatment that addresses the body as well as the mind, delivered in a way that reaches the people who need it most. Watch this space — the results could reshape how we think about food, energy, and the brain.